867 Stock Overview
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
China Medical System Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$7.07 |
| 52 Week High | HK$15.86 |
| 52 Week Low | HK$6.85 |
| Beta | 0.80 |
| 1 Month Change | -43.53% |
| 3 Month Change | -40.19% |
| 1 Year Change | -46.68% |
| 3 Year Change | -60.90% |
| 5 Year Change | 1.14% |
| Change since IPO | -42.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| 867 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | 0.1% | 3.7% | 3.6% |
| 1Y | -46.7% | -17.6% | -10.1% |
Return vs Industry: 867 underperformed the Hong Kong Pharmaceuticals industry which returned -17.6% over the past year.
Return vs Market: 867 underperformed the Hong Kong Market which returned -10.1% over the past year.
Price Volatility
| 867 volatility | |
|---|---|
| 867 Average Weekly Movement | 11.0% |
| Pharmaceuticals Industry Average Movement | 6.4% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.6% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 867's share price has been volatile over the past 3 months.
Volatility Over Time: 867's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 5,701 | Kong Lam | web.cms.net.cn/zh/home/ |
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. Its products include VALTOCO, a diazepam nasal spray to treat seizure clusters; Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu to treat acute heart failure; Deanxit for mild-to-moderate depression, anxiety, and psychosomatic affections; METOJECT, a methotrexate injection for recalcitrant disabling psoriasis; and Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis. The company also offers Salofalk for treating Ulcerative Colitis and Crohn’s disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; ILUMETRI, a tildrakizumab injection to treat moderate-tosevere plaque psoriasis; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar.
China Medical System Holdings Limited Fundamentals Summary
| 867 fundamental statistics | |
|---|---|
| Market cap | HK$17.25b |
| Earnings (TTM) | HK$2.59b |
| Revenue (TTM) | HK$8.66b |
6.6x
P/E Ratio2.0x
P/S RatioIs 867 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 867 income statement (TTM) | |
|---|---|
| Revenue | CN¥8.01b |
| Cost of Revenue | CN¥1.94b |
| Gross Profit | CN¥6.08b |
| Other Expenses | CN¥3.68b |
| Earnings | CN¥2.40b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.98 |
| Gross Margin | 75.82% |
| Net Profit Margin | 29.96% |
| Debt/Equity Ratio | 8.3% |
How did 867 perform over the long term?
See historical performance and comparisonDividends
6.0%
Current Dividend Yield40%
Payout RatioDoes 867 pay a reliable dividends?
See 867 dividend history and benchmarks| China Medical System Holdings dividend dates | |
|---|---|
| Ex Dividend Date | May 13 2024 |
| Dividend Pay Date | May 23 2024 |
| Days until Ex dividend | 17 days |
| Days until Dividend pay date | 27 days |
Does 867 pay a reliable dividends?
See 867 dividend history and benchmarks